Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis

MLA

Ruiz-Palacios, Guillermo M., et al. “Immunogenicity of AS03-Adjuvanted and Non-Adjuvanted Trivalent Inactivated Influenza Vaccines in Elderly Adults: A Phase 3, Randomized Trial and Post-Hoc Correlate of Protection Analysis.” Human Vaccines and Immunotherapeutics, vol. 12, no. 12, Jan. 2016, pp. 3043–55. EBSCOhost, https://doi.org/10.1080/21645515.2016.1219809.

APA

Ruiz-Palacios, G. M., Leroux-Roels, G., Beran, J., Devaster, J.-M., Esen, M., Launay, O., McElhaney, J. E., van Essen, G. A., Benoit, A., Claeys, C., Dewé, W., Durand, C., Duval, X., Falsey, A. R., Feldman, G., Galtier, F., Gervais, P., Hwang, S.-J., McNeil, S., … Influence65 study group. (2016). Immunogenicity of AS03-adjuvanted and non-adjuvanted trivalent inactivated influenza vaccines in elderly adults: A Phase 3, randomized trial and post-hoc correlate of protection analysis. Human Vaccines and Immunotherapeutics, 12(12), 3043–3055. https://doi.org/10.1080/21645515.2016.1219809

Chicago

Ruiz-Palacios, Guillermo M, Geert Leroux-Roels, Jiri Beran, Jeanne-Marie Devaster, Meral Esen, Odile Launay, Janet E McElhaney, et al. 2016. “Immunogenicity of AS03-Adjuvanted and Non-Adjuvanted Trivalent Inactivated Influenza Vaccines in Elderly Adults: A Phase 3, Randomized Trial and Post-Hoc Correlate of Protection Analysis.” Human Vaccines and Immunotherapeutics 12 (12): 3043–55. doi:10.1080/21645515.2016.1219809.